Tokyo Tape
Sign in
← Soiken Holdings

Quarterly report · Q2

2385.TEDINET S100Q4ZE
Period2022-07-01 → 2022-12-31
Filed2023-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥4.2bn2022-07-01 → 2022-12-31Cons.Net sales
Revenue¥9.3bn2021-07-01 → 2022-06-30Cons.Net sales (5-year summary)
Revenue¥5.2bn2021-07-01 → 2021-12-31Cons.Net sales
Operating income¥345m2022-07-01 → 2022-12-31Cons.Operating income
Operating income¥584m2021-07-01 → 2021-12-31Cons.Operating income
Ordinary income¥345m2022-07-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥1.3bn2021-07-01 → 2022-06-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥629m2021-07-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥345m2022-07-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥628m2021-07-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥209m2022-07-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥810m2021-07-01 → 2022-06-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥415m2021-07-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥213m2022-07-01 → 2022-12-31Cons.Profit loss
Net income¥421m2021-07-01 → 2021-12-31Cons.Profit loss
Total assets¥8.0bnat 2022-12-31Cons.Assets
Total assets¥8.5bnat 2022-06-30Cons.Assets
Total assets¥8.1bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥1.0bnat 2022-12-31Cons.Liabilities
Total liabilities¥1.6bnat 2022-06-30Cons.Liabilities
Net assets / equity¥6.9bnat 2022-12-31Cons.Net assets
Net assets / equity¥6.8bnat 2022-06-30Cons.Net assets
Net assets / equity¥6.5bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥5.5bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥6.0bnat 2022-06-30Cons.Cash and deposits
Cash & equivalents¥5.5bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥6.0bnat 2022-06-30Cons.Cash and cash equivalents
Cash & equivalents¥5.3bnat 2021-12-31Cons.Cash and cash equivalents
Cash & equivalents¥4.3bnat 2021-06-30dCons.Cash and cash equivalents
Operating cash flow−¥328m2022-07-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥2.1bn2021-07-01 → 2022-06-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.2bn2021-07-01 → 2021-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥27m2022-07-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥245m2021-07-01 → 2022-06-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥23m2021-07-01 → 2021-12-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥130m2022-07-01 → 2022-12-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥130m2021-07-01 → 2022-06-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥129m2021-07-01 → 2021-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥82022-07-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥7.472022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥30.952021-07-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥15.862021-07-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥12.712021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio84.4%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio78.3%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio77.4%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 48
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-07-01 → 2022-12-31−¥2m
Reconciling Itemsreconcilingrevenue external2022-07-01 → 2022-12-31¥900,000
Reconciling Itemsreconcilingrevenue intersegment2022-07-01 → 2022-12-31−¥3m
Reconciling Itemsreconcilingsegment profit2022-07-01 → 2022-12-31−¥155m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue2022-07-01 → 2022-12-31¥258m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue external2022-07-01 → 2022-12-31¥258m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentsegment profit2022-07-01 → 2022-12-31¥32m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue2022-07-01 → 2022-12-31¥2.0bn
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue external2022-07-01 → 2022-12-31¥2.0bn
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentsegment profit2022-07-01 → 2022-12-31¥398m
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue2022-07-01 → 2022-12-31¥1.4bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue external2022-07-01 → 2022-12-31¥1.4bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentsegment profit2022-07-01 → 2022-12-31−¥18m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue2022-07-01 → 2022-12-31¥279m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue external2022-07-01 → 2022-12-31¥277m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue intersegment2022-07-01 → 2022-12-31¥3m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentsegment profit2022-07-01 → 2022-12-31¥43m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue2022-07-01 → 2022-12-31¥314m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue external2022-07-01 → 2022-12-31¥314m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentsegment profit2022-07-01 → 2022-12-31¥45m
—segment totalrevenue2022-07-01 → 2022-12-31¥4.2bn
—segment totalrevenue external2022-07-01 → 2022-12-31¥4.2bn
—segment totalrevenue intersegment2022-07-01 → 2022-12-31¥3m
—segment totalsegment profit2022-07-01 → 2022-12-31¥500m
Reconciling Itemsreconcilingrevenue2021-07-01 → 2021-12-31−¥2m
Reconciling Itemsreconcilingrevenue external2021-07-01 → 2021-12-31¥900,000
Reconciling Itemsreconcilingrevenue intersegment2021-07-01 → 2021-12-31−¥3m
Reconciling Itemsreconcilingsegment profit2021-07-01 → 2021-12-31−¥162m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue2021-07-01 → 2021-12-31¥231m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue external2021-07-01 → 2021-12-31¥231m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentsegment profit2021-07-01 → 2021-12-31−¥6m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue2021-07-01 → 2021-12-31¥2.7bn
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue external2021-07-01 → 2021-12-31¥2.7bn
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentsegment profit2021-07-01 → 2021-12-31¥659m
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue2021-07-01 → 2021-12-31¥1.6bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue external2021-07-01 → 2021-12-31¥1.6bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentsegment profit2021-07-01 → 2021-12-31−¥22m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue2021-07-01 → 2021-12-31¥360m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue external2021-07-01 → 2021-12-31¥358m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue intersegment2021-07-01 → 2021-12-31¥3m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentsegment profit2021-07-01 → 2021-12-31¥63m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue2021-07-01 → 2021-12-31¥315m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue external2021-07-01 → 2021-12-31¥315m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentsegment profit2021-07-01 → 2021-12-31¥52m
—segment totalrevenue2021-07-01 → 2021-12-31¥5.2bn
—segment totalrevenue external2021-07-01 → 2021-12-31¥5.1bn
—segment totalrevenue intersegment2021-07-01 → 2021-12-31¥3m
—segment totalsegment profit2021-07-01 → 2021-12-31¥746m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 442
ItemContextValueUnit
Property plant and equipmentPrior1YearInstant36375000JPY
Property plant and equipmentCurrentQuarterInstant52792000JPY
Other iaPrior1YearInstant49290000JPY
Other iaCurrentQuarterInstant50466000JPY
Intangible assetsPrior1YearInstant49290000JPY
Intangible assetsCurrentQuarterInstant50466000JPY
Investment securitiesPrior1YearInstant20738000JPY
Investment securitiesCurrentQuarterInstant20738000JPY
Other ioaPrior1YearInstant186587000JPY
Other ioaCurrentQuarterInstant161993000JPY
Investments and other assetsPrior1YearInstant207326000JPY
Investments and other assetsCurrentQuarterInstant182731000JPY
Noncurrent assetsPrior1YearInstant292992000JPY
Noncurrent assetsCurrentQuarterInstant285991000JPY
AssetsPrior1YearInstant8489524000JPY
AssetsCurrentQuarterInstant7969219000JPY
Accounts payable tradePrior1YearInstant459693000JPY
Accounts payable tradeCurrentQuarterInstant190000000JPY
Income taxes payablePrior1YearInstant291293000JPY
Income taxes payableCurrentQuarterInstant110944000JPY
Contract liabilitiesPrior1YearInstant534015000JPY
Contract liabilitiesCurrentQuarterInstant460190000JPY
Other clPrior1YearInstant339658000JPY
Other clCurrentQuarterInstant259931000JPY
Current liabilitiesPrior1YearInstant1624660000JPY
Current liabilitiesCurrentQuarterInstant1021066000JPY
Net defined benefit liabilityPrior1YearInstant17496000JPY
Net defined benefit liabilityCurrentQuarterInstant18271000JPY
Noncurrent liabilitiesPrior1YearInstant17496000JPY
Noncurrent liabilitiesCurrentQuarterInstant18271000JPY
LiabilitiesPrior1YearInstant1642157000JPY
LiabilitiesCurrentQuarterInstant1039338000JPY
Capital stockPrior1YearInstant1836587000JPY
Capital stockCurrentQuarterInstant1836587000JPY
Capital surplusPrior1YearInstant1899955000JPY
Capital surplusCurrentQuarterInstant1899955000JPY
Retained earningsPrior1YearInstant2911255000JPY
Retained earningsCurrentQuarterInstant2989669000JPY
Shareholders equityPrior1YearInstant6647798000JPY
Shareholders equityCurrentQuarterInstant6726212000JPY
Non controlling interestsPrior1YearInstant199568000JPY
Non controlling interestsCurrentQuarterInstant203668000JPY
Net assetsPrior1YearInstant6847367000JPY
Net assetsCurrentQuarterInstant6929881000JPY
Liabilities and net assetsPrior1YearInstant8489524000JPY
Liabilities and net assetsCurrentQuarterInstant7969219000JPY
Net salesPrior1YTDDuration5150509000JPY
Net salesCurrentYTDDuration4223839000JPY
Cost of salesPrior1YTDDuration2785877000JPY
Cost of salesCurrentYTDDuration2200652000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-06-30pass
balance sheet identityconsolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2021-07-01/2021-12-31pass
statement vs summary · operating cash flowconsolidated 2022-07-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-07-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-07-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass
statement vs summary · total assetsconsolidated 2022-12-31pass